A carregar...
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β(2)-adrenoreceptor agonist (uLABA)
OBJECTIVE: The clinical pharmacokinetics of AZD3199, an ultra-long-acting β(2)-agonist, were investigated in healthy volunteers and patients with asthma or chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS: Five studies are presented: one single ascending dose study in healthy Cauc...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4330041/ https://ncbi.nlm.nih.gov/pubmed/25709399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S66049 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|